The headline is right
The court elimination of Phizer’s Norvasc patent saved Ratiopharm about $170-million a year. Due to an editing error, the wrong figure appeared in The Price Is Wrong by Aidan Hollis in the Financial Post on Tuesday. Link
Thanks, Morgan!
Report an error